Our 24th Planova Workshop will take place in the beautiful city of Florence
The workshop will include presentations on virus filtration theory and practice, microfiltration for cell culture clarification, industry-based applications, and a preview of our strategic applications. It will be a fantastic opportunity to gain knowledge and learn more about advanced techniques that can be applied to your process.
Eminent users of Planova and BioOptimal™/Microza®, with direct expertise in the use of virus removal filtration, tangential microfiltration, process scale-up, and bioprocess technologies will share their knowledge and experience in both DSP and USP. Authorities will also provide important updates on the latest regulations. Our global bioprocess team will provide an inside look at our new product PLANOVA S20N and services.
We look forward to welcoming you to Florence!”
Chair: Dr. Thomas Kreil, Associate Professor of Virology, Vice President, Global Pathogen Safety, Takeda
Dr. Johannes Bluemel,
Head of Virus Safety Section, Department of Virology, Paul-Ehrich Institue
Dr. Anja Tessarz,
Associate Director & SME Viral Clearance, R&D, Charles River
Dr. Andy Bailey,
CEO / Operations Director, ViruSure GmbH
Dr. Merche Faro,
New Process Development Senior Manager, Scientific Innovation Office, Plasma R&D, Grifols
I.M.M. Prins-de Nijs,
Senior Purification Specialist, Prothya
Dr. Remo Leisi,
Senior Manager, Translational Research & Innovation Global Pathogen Safety, R&D, CSL
Dr. Takeru Urayama,
Manager, Research & Development Division, Central Research Laboratory, JBPO
Ms. Megan McClure,
Process Development Scientist, Just-Evotec Biologics
Dr. Bas Kokke,
Principal Scientist, Downstream Processing, Byondis
Ms. Deepti Neelkantan,
Senior Principal Scientist, Downstream processing, Mab platform, FujiFilm
Ms. Yuka Ogino,
Researcher, Biologics Technology Research Laboratories I, Group III, Biologics Division, Daiichi Sankyo
Addition of nanofiltration step at early bioprocess development stage
Dr. Natalia Ugulava, Senior Principal Scientist, EBPD/VRD, Pfizer
Viral Clearance Study Optimization for Planova Virus Removal Filters and Technical Support By Asahi Kasei
Achraf Jazi, Product Manager, Product Management and Business Development, Asahi Kasei Bioprocess Europe
End-to-end continuous process for mAb purification implementing total flow-through integrated polishing process
Haiko Ovca Fischer, Product Manager, Product Management and Business Development, Asahi KaseiBioprocess Europe
Massachusetts Training Center— A Trusted Partner for Planova™ Filtration products, Technologies, and More
Sarah El Mossalamy, Senior Account Manager, Account Management/ Bioprocess- Planova, Asahi Kasei Bioprocess America
Proof of Concept Performance with Planova S20N Novel Virus Removal Filter, “Processing more, Faster”
Yugo Uchida, Manager Global Marketing, Scientific Affairs, Bioprocess Division, Asahi Kasei Medical
Virus Safety against Emerging Viruses: History and Advances of Challenges in Viral Filtration Technology
Pinar Carkci,Product Manager, Product Management & Business Development, Asahi Kasei Bioprocess Europe
Bioprocess Products For Protein Purification: BioOptimal™ MF-SL
Konstantin Doshishti-Agolli, Senior Product Manager & BioOptimal TFF Specialist, Product Management & Business Development, Asahi Kasei Bioprocess Europe
Cologne Technical Center — Your Training Center for Planova™ Filtration Technology and More
Daniel Braune, Laboratory Technician, Research & Development, Asahi Kasei Bioprocess Europe
Numerical Calculations of Membrane Structure, Virus Removal Performance, and Filtration Behavior of Virus Filters Based on a Heterogeneous Membrane Structural Model Comprising Multiple Layers with Different Pore Size Distributions
Hironobu Shirataki, Senior Consultant (Scientific Affairs), Global Marketing, Bioprocess Division, Asahi Kasei Medical Co., Ltd
Dr. Cristina Peixoto,
Head of DSP Development Lab, Coordinator of Bioproduction Unit, Animal Cell Technology Unit, Bioproduction Unit, iBET
Dr. Alois Jungbauer,
Institute of Bioprocess Science and Engineering, Department of Biotechnology, Boku
Mr. Manuel Quirós,
Principal Scientist/Cultivation Specialist Biotech and Rare Diseases API Manufacturing Development, NovoNordisk
Mr. Mark Brower,
Senior Director, MSD
Dr. Eleonora Widmer,
Head Global Pathogen Safety, R&D, CSL Behring
Dr. Thomas Kreil,
Associate Professor of Virology, Vice President, Global Pathogen Safety, Takeda
Mike Xenelis,
Senior Director, Alexion
Ms. Lara Fernandez Cerezo,
Associate Principal Scientist, MSD
Mr. Matt Macknight,
MSAT Manager, Lonza